Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Operating Expenses (2016 - 2025)

iBio (IBIO) has disclosed Operating Expenses for 16 consecutive years, with $9.4 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses rose 104.48% to $9.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.8 million through Dec 2025, up 61.74% year-over-year, with the annual reading at $19.0 million for FY2025, 12.71% up from the prior year.
  • Operating Expenses for Q4 2025 was $9.4 million at iBio, up from $6.1 million in the prior quarter.
  • The five-year high for Operating Expenses was $10.6 million in Q4 2022, with the low at $3.6 million in Q2 2024.
  • Average Operating Expenses over 5 years is $6.5 million, with a median of $5.7 million recorded in 2025.
  • The sharpest move saw Operating Expenses soared 159.81% in 2021, then tumbled 57.48% in 2023.
  • Over 5 years, Operating Expenses stood at $7.2 million in 2021, then surged by 46.22% to $10.6 million in 2022, then plummeted by 57.48% to $4.5 million in 2023, then rose by 2.74% to $4.6 million in 2024, then skyrocketed by 104.48% to $9.4 million in 2025.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $9.4 million, $6.1 million, and $5.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.